Announcements Trials
Browse Landscape

Phase

Phase 1 7Phase 2 6Phase 1/2 6Phase 3 2Phase NA 1Phase EARLY_PHASE1 1Phase 4 1

Status

Terminated 2Completed 2Recruiting 1Active not recruiting 1

Sponsor Class

INDUSTRY 4OTHER 2

Study Type

Interventional 6

Sponsor

Cancer Type

Sarcoma 1Lymphoid 1Genitourinary 1Dermatologic 1CNS 1Breast 1

Conditions

Triple Negative Breast Neoplasms 1Synovitis, Pigmented Villonodular 1Prostatic Neoplasms 1Pathologic Complete Response 1Neoplasms 1Melanoma 1Hodgkin Disease 1Hemangiosarcoma 1Glioblastoma 1Giant Cell Tumor of Tendon Sheath 1Breast Neoplasms 1Brain Neoplasms 1

Interventions

Cisplatin 1514Carboplatin 1416Cyclophosphamide 1359Gemcitabine 1235Bevacizumab 1223Paclitaxel 1210Radiotherapy 1173Docetaxel 1079pembrolizumab 1026Oxaliplatin 934Capecitabine 898Fluorouracil 832Rituximab 729Doxorubicin 683Nivolumab 679Dexamethasone 665Etoposide 660Irinotecan 622Leucovorin 574Pemetrexed 508Drug Therapy 491Cetuximab 481Trastuzumab 467Cytarabine 466Magnetic Resonance Spectroscopy 457Filgrastim 446Prednisone 432Lenalidomide 409Specimen Handling 407Temozolomide 400

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Phase 2 × pexidartinib × Clear all
NCT01042379 2026-05-06

I-SPY

QuantumLeap Healthcare Collaborative

Phase 2 Recruiting
5,000 enrolled
BreastSarcoma

Pathologic Complete Response, Breast Neoplasms, Hemangiosarcoma, Neoplasms, Triple Negative Breast Neoplasms

NCT04703322 2026-03-04

A Study of Pexidartinib in Tenosynovial Giant Cell Tumor in Japan

Daiichi Sankyo

Phase 2 Active not recruiting
9 enrolled 10 charts

Giant Cell Tumor of Tendon Sheath, Synovitis, Pigmented Villonodular

NCT02071940 2021-08-12

PIANO

The Christie NHS Foundation Trust

Phase 2 Completed
7 enrolled
Dermatologic

Melanoma

NCT01217229 2020-06-30

Safety and Efficacy Study of PLX3397 in Adults With Relapsed or Refractory Hodgkin Lymphoma

Daiichi Sankyo

Phase 2 Completed
20 enrolled 7 charts
Lymphoid

Hodgkin Disease

NCT01499043 2020-03-04

Pilot Study of PLX3397 in Patients With Advanced Castration-Resistant Prostate Cancer (CRPC)

Daiichi Sankyo

Phase 2 Terminated
6 enrolled 6 charts
Genitourinary

Prostatic Neoplasms

NCT01349036 2020-03-03

A Phase 2 Study of PLX3397 in Patients With Recurrent Glioblastoma

Daiichi Sankyo

Phase 2 Terminated
38 enrolled 13 charts
CNS

Brain Neoplasms, Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡